Immune response to 2009 H1N1 vaccine in HIV-infected adults in Northern Thailand

• Main Authors: Chotirosniramit N., Sugandhavesa P., Aurpibul L., Thetket S., Kosashunhanan N., Supindham T., Wongkulab P., Kaewpoowat Q., Chaiklang K., Kaewthip O., Sroysuwan P., Wongthanee A., Lerdsamran H., Puthavathana P., Suparatpinyo K.
• Format: Journal
• Published: 2017
• Online Access: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84872231259&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/42721
• Institution: Chiang Mai University

Background: In late 2009, the Thai Ministry of Public Health provided two million doses of the monovalent pandemic influenza H1N1 2009 vaccine (Panenza® Sanofi Pasteur), which was the only vaccine formulation available in Thailand, to persons at risk of more severe manifestations of the disease incl...